Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Lymphoma

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 9 articles: HTML format

Single Articles

October 2023
1. JIN C, Zhou D, Li J, Bi L, et al
   Single‑cell multi‑omics advances in lymphoma research (Review).
   Oncol Rep. 2023;50:184.
   PubMed     Abstract available
   
   
   July 2023
2. CHEN Y, Tao H, Wang F, Wu P, et al
   Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathway.
   Oncol Rep. 2023;50:147.
   PubMed     Abstract available
   
   
   May 2023
3. ZENG H, Wang J, Xu B, Deng H, et al
   Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma.
   Oncol Rep. 2023;49:88.
   PubMed     Abstract available
   
   
   
4. WANG H, Xiong M, Hu Y, Sun Y, et al
   [Retracted] MicroRNA‑19b inhibits proliferation of gastric cancer cells by targeting B‑cell CLL/lymphoma 3.
   Oncol Rep. 2023;49:104.
   PubMed     Abstract available
   
   
   February 2023
5. XING X, Liu M, Wang X, Guo Q, et al
   Promoting effects of calponin 3 on the growth of diffuse large B‑cell lymphoma cells.
   Oncol Rep. 2023;49:46.
   PubMed     Abstract available
   
   
   January 2023
6. CAO L, Zhang M, Zhang Y, Ji B, et al
   Progress of radiological‑pathological workflows in the differential diagnosis between primary central nervous system lymphoma and high‑grade glioma (Review).
   Oncol Rep. 2023;49:20.
   PubMed     Abstract available
   
   
   June 2022
7. LALIC H, Aurer I, Batinic D, Visnjic D, et al
   Bendamustine: A review of pharmacology, clinical use and immunological effects (Review).
   Oncol Rep. 2022;47.
   PubMed     Abstract available
   
   
   March 2022
8. KADOTA A, Moriguchi M, Watanabe T, Sekine Y, et al
   A pyridiniumtype fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of betacatenin.
   Oncol Rep. 2022;47.
   PubMed     Abstract available
   
   
   January 2022
9. FRAZZI R, Cusenza VY, Pistoni M, Canovi L, et al
   KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
   Oncol Rep. 2022;47.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.